These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12198364)

  • 21. Influenza vaccine--a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate.
    Plotkin E; Bernheim J; Ben-Chetrit S; Mor A; Korzets Z
    Nephrol Dial Transplant; 2000 May; 15(5):740-1. PubMed ID: 10809833
    [No Abstract]   [Full Text] [Related]  

  • 22. Early detection of drug interactions utilizing a computerized drug prescription handling system-focus on cerivastatin-gemfibrozil.
    Morera T; Gervasini G; Carrillo JA; Benitez J
    Eur J Clin Pharmacol; 2004 Feb; 59(12):917-21. PubMed ID: 14735257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
    Kind AH; Zakowski LJ; McBride PE
    WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations.
    Oldemeyer JB; Lund RJ; Koch M; Meares AJ; Dunlay R
    Cardiology; 2000; 94(2):127-8. PubMed ID: 11173785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayer pulls cerivastatin (Baycol) from market.
    Wooltorton E
    CMAJ; 2001 Sep; 165(5):632. PubMed ID: 11563216
    [No Abstract]   [Full Text] [Related]  

  • 26. Rhabdomyolysis with HMG CoA reductase inhibitors: a class effect?
    Langford NJ; Kendall MJ
    J Clin Pharm Ther; 2001 Dec; 26(6):391-5. PubMed ID: 11722675
    [No Abstract]   [Full Text] [Related]  

  • 27. Myoglobinuria and COX deficiency in a patient taking cerivastatin and gemfibrozil.
    Arenas J; Fernández-Moreno MA; Molina JA; Fernández V; del Hoyo P; Campos Y; Calvo P; Martín MA; García A; Moreno T; Martínez-Salio A; Börnstein B; Bermejo F; Cabello A; Garesse R
    Neurology; 2003 Jan; 60(1):124-6. PubMed ID: 12525734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual hepatic metabolism of cerivastatin--clarifications.
    Guyton JR; Dujovne CA; Illingworth DR
    Am J Cardiol; 1999 Aug; 84(4):497. PubMed ID: 10468102
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe rhabdomyolysis related to cerivastatin without gemfibrozil.
    Hyman DJ; Henry A; Taylor A
    Ann Intern Med; 2002 Jul; 137(1):74. PubMed ID: 12093260
    [No Abstract]   [Full Text] [Related]  

  • 30. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
    Landesman KA; Stozek M; Freeman NJ
    Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fatal rhabdomyolysis caused by cerivastatin].
    Scheen AJ
    Rev Med Liege; 2001 Aug; 56(8):592-4. PubMed ID: 11584446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe rhabdomyolysis and cerivastatin-gemfibrozil combination therapy.
    Roca B; Calvo B; Monferrer R
    Ann Pharmacother; 2002 Apr; 36(4):730-1. PubMed ID: 11936088
    [No Abstract]   [Full Text] [Related]  

  • 33. Statin safety.
    Foxton J
    Nurs Stand; 2001 Sep 19-25; 16(1):20. PubMed ID: 11977679
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rhabdomyolysis induced by statins].
    Hamano T; Muto T; Kuriyama M
    Nihon Naika Gakkai Zasshi; 2007 Aug; 96(8):1646-51. PubMed ID: 17802715
    [No Abstract]   [Full Text] [Related]  

  • 35. [Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States].
    Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):41-5. PubMed ID: 16541751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy.
    Marais GE; Larson KK
    Ann Intern Med; 1990 Feb; 112(3):228-30. PubMed ID: 2297197
    [No Abstract]   [Full Text] [Related]  

  • 37. Statin-fibrate combination therapy.
    Shek A; Ferrill MJ
    Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemfibrozil greatly increases plasma concentrations of cerivastatin.
    Backman JT; Kyrklund C; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2002 Dec; 72(6):685-91. PubMed ID: 12496749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential for conflict of interest in the evaluation of suspected adverse drug reactions: a counterpoint.
    Strom BL
    JAMA; 2004 Dec; 292(21):2643-6. PubMed ID: 15572722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.